This guide has been translated in different languages and is designed to help inform pregnant women about Respiratory Syncytial Virus (RSV), its symptoms, and preventative measures. It also provides information about how receiving ABRYSVO during pregnancy can help prevent RSV in infants.

Before prescribing, please review Product Information available here.

▼This vaccine is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems

PBS Information: ABRYSVO is NIP listed for pregnant women - refer to the NIP for details.